The Role of Inflammation in Tumour Growth and Tumour Suppression

  1. Derek J. Chadwick Organizer,
  2. Jamie A. Goode
  1. Thomas Blankenstein

Published Online: 7 OCT 2008

DOI: 10.1002/0470856734.ch15

Cancer and Inflammation: Novartis Foundation Symposium 256

Cancer and Inflammation: Novartis Foundation Symposium 256

How to Cite

Blankenstein, T. (2008) The Role of Inflammation in Tumour Growth and Tumour Suppression, in Cancer and Inflammation: Novartis Foundation Symposium 256 (eds D. J. Chadwick and J. A. Goode), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470856734.ch15

Author Information

  1. Max-Delbrück-Centrum for Molecular Medicine, Robert-Rössle Strasse 10, 13092 Berlin and Institute of Immunology, Free University Berlin, Hindenburgdamm 30, 12200 Berlin, Germany

Publication History

  1. Published Online: 7 OCT 2008
  2. Published Print: 23 JAN 2004

Book Series:

  1. Novartis Foundation Symposia

Book Series Editors:

  1. Novartis Foundation

ISBN Information

Print ISBN: 9780470855102

Online ISBN: 9780470856734

SEARCH

Summary

The relationship between inflammation and tumour growth is poorly understood. The quality, quantity and time point of the inflammatory response may decide whether inflammation supports or inhibits tumour growth. Three examples are given that illustrate the different role of inflammation for tumour growth. It will be shown that tumour infiltrating macrophages can contribute to tumour rejection, can be essential for tumour growth or can occur as innocent bystander cells in tumours. Then it will be shown that the timely arrival of T cells at the tumour site is critical for tumour rejection and that non-bone marrow-derived tumour stromal cells are important targets during tumour rejection. Finally, a protective inflammatory response against the chemical carcinogen methylcholanthrene (MCA) will be discussed. This response is related to a tissue repair response induced by the tissue damaging effects of the carcinogen in the course of which MCA is encapsulated and no longer able to induce tumours.